STELLULAR
Live / Allowed — Fifth extension granted (statement of use) (as of 20 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Dec 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97708044
- Mark type
- Word mark
- Filed
- 07 Dec 2022
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Blood platelets and stem cell derived products for medical or clinical use in the nature of pharmaceutical preparations for the treatment of a variety of indications such as ocular surface diseases or injury, chronic wound healing, osteoarthritis, alopecia, and others that platelet-rich plasma is being used to treat; Blood platelet variants for medical or clinical use; Pharmaceutical compositions for drug delivery in the form of topical drops, gel-like/ointment formulations, and injectable solutions comprised of blood platelets, blood platelet variants, and stem cell derived products in the nature of cells or any components of cells that facilitate the delivery of pharmaceutical preparations
Owner
- Stellular Bio, Inc., Watertown, MA, US
- Stellular Bio, Inc., Watertown, MA, US
Prosecution history
- 20 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2026 — SOU EXTENSION 5 GRANTED
- 17 Jun 2026 — SOU EXTENSION 5 FILED
- 20 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2025 — SOU EXTENSION 4 GRANTED
- 14 Dec 2025 — SOU EXTENSION 4 FILED
- 14 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jun 2025 — SOU EXTENSION 3 GRANTED
- 02 Jun 2025 — SOU EXTENSION 3 FILED
- 02 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — SOU EXTENSION 2 GRANTED